Low E-cadherin expression is associated with an increased risk of late cervical metastasis in stage I and II oral cancer patients [17], and the overexpression of SIP1 and downregulation of E-cadherin predict delayed neck metastasis in stage I and II oral tongue carcinoma after partial glossectomy [18]. The gene discussed is CDH1; the disease is lip and oral cavity carcinoma.